Benitec Biopharma Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | — | $2.9M | $4.1M |
| FY2023 | — | $202.0K | $2.5M |
| FY2024 | — | $47.2M | $50.9M |
| FY2025 | — | $97.3M | $97.7M |
| FY2026 | — | $177.0M | $180.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | — | $2.9M | $4.1M |
| FY2023 | — | $202.0K | $2.5M |
| FY2024 | — | $47.2M | $50.9M |
| FY2025 | — | $97.3M | $97.7M |
| FY2026 | — | $177.0M | $180.0M |